NHLBI Responds to Center for Science in the Public Interest Letter on Cholesterol
Guidelines
The following letter from NHLBI Acting Director Dr. Barbara Alving to Merrill
Goozner of Center for Science in the Public Interest (CSPI) responds to a
letter initiated by CSPI that questioned the scientific basis and objectivity
of the 2001 Adult Treatment Panel III (ATP III) recommendations for cholesterol
management and a 2004 update commenting on these recommendations, which were
developed by the National Cholesterol Education Program (NCEP). The September
23 letter, signed by CSPI Executive Director Michael Jacobson, PhD, and 34
MD’s and PhD’s, called on NCEP to form an independent panel to
re-review the data underlying these clinical practice guidelines. Dr. Alving’s
response describes the abundant evidence that supports cholesterol lowering
and states, “The ATP III recommendations have a sound scientific basis,
and NHLBI has used a careful development process, including multiple levels
of review, to ensure the integrity and objectivity of the guidelines. Thus,
the Institute does not believe a re-review of the data is warranted at this
time...When the results of the current ongoing trials are available, the Institute
will consider the formation of a new panel to update the existing guidelines.”
HTML version
PDF version (49 K, 11 pages)
Home Page
Clinical
Guidelines Page Cholesterol
Information for Professionals
|
Link to PDF version |